Exact Therapeutics AS

EXTX · Oslo Børs · Healthcare

0.68NOK +3.8%last day

Price as of 2 October 2026

The price over the past year, with dividends: −70.1%

Performance

1 month

−13.5%

1 year

−70.1%

3 years, per year

−65.9%

5 years, per year

−49.6%

Largest fall, 3 years

−96.8%

Below the peak now

−98.3%

Volatility, 1 year

136.9%

Return with dividends reinvested.

Key figures

P/E

negative earnings

P/B

1.5

Dividend yield

0.0%

Return on equity

−160.1%

Net margin

–

Market value

4 m USD

Quality, value and trend

Where Exact Therapeutics stands against every Nordic stock today. 100 is best.

Quality18

Profitability and a sound balance sheet over time. Better than 18% of Nordic stocks.

Value20

The price measured against earnings, assets and cash flow. Better than 20% of Nordic stocks.

Trend10

The price development over the past year. Better than 10% of Nordic stocks.

Combined2

Quality, value and trend together. Better than 2% of Nordic stocks.

About Exact Therapeutics

Exact Therapeutics AS is a company in healthcare, listed on Oslo Børs. The share trades in NOK. It has around 11 employees.

EXACT Therapeutics AS, a clinical stage biopharmaceutical company, develops a novel ultrasound-mediated technology platform for targeted therapeutic enhancement, Acoustic Cluster Therapy (ACT) in Norway. The ACT is an approach to ultrasound-mediated, targeted drug enhancement with the potential to amplify the clinical utility of a range of therapeutic agents across various applications, including oncology, neurological conditions, and gene therapy.

See the full analysis in InvestWiser.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

See the full analysis